More articles from Review
Myasthenia gravis: Newer therapies offer sustained improvementThe prognosis has dramatically improved; the death rate used to be 75%, now it is 4.5%.
- Sleep disturbances in cancer patients: Underrecognized and undertreated
In cancer patients, sleep disturbances are a treatable problem that profoundly affect all aspects of quality of life.
- The jugular venous pressure revisited
Few physical findings are as useful but as undervalued as the estimation of the jugular venous pressure.
- Hepatocellular carcinoma: Options for diagnosing and managing a deadly disease
Because early diagnosis improves the chances of survival, it is important to identify patients who would benefit from surveillance.
- Antisynthetase syndrome: Not just an inflammatory myopathy
With its variety of clinical presentations, it should be in the differential diagnosis for patients with unexplained interstitial lung disease.
- Transient ischemic attack: Omen and opportunity
A transient ischemic attack (TIA) is often the precursor of stroke. As such, every TIA deserves to be taken seriously.
- Biomarkers in the emergency workup of chest pain: Uses, limitations, and future
Cardiac biomarkers are only one piece of the clinical picture, albeit an important one.
- Incidental ovarian cysts: When to reassure, when to reassess, when to refer
Most cysts are benign, but a few are malignant, with a notoriously poor survival rate. How can we tell if a patient truly needs surgery?
- The FREEDOM trial: In appropriate patients with diabetes and multivessel coronary artery disease, CABG beats PCI
A large randomized trial finds bypass grafting superior to percutaneous intervention in a highly selected population.
- How to interpret surveys in medical research: A practical approach
Was the survey well designed? Was the sample appropriate and the response rate adequate? And do the data support the conclusions?
